Page last updated: 2024-08-26

peptide elongation factor 2 and Cancer of Skin

peptide elongation factor 2 has been researched along with Cancer of Skin in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gschwendt, M; Kittstein, W; Marks, F1

Other Studies

1 other study(ies) available for peptide elongation factor 2 and Cancer of Skin

ArticleYear
Ciclosporin inhibits phorbol-ester-induced hyperplastic transformation and tumor promotion in mouse skin probably by suppression of Ca2+/calmodulin-dependent processes such as phosphorylation of elongation factor 2.
    Skin pharmacology : the official journal of the Skin Pharmacology Society, 1988, Volume: 1, Issue:2

    Topics: Animals; Calcium; Calmodulin; Cell Transformation, Neoplastic; Chromatography, DEAE-Cellulose; Cocarcinogenesis; Cycloheximide; Cyclosporins; Cytosol; Electrophoresis, Polyacrylamide Gel; Mice; Peptide Elongation Factor 2; Peptide Elongation Factors; Phosphorus Radioisotopes; Phosphorylation; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate

1988